News Releases News Releases HOME HOME

December 22, 2004

For people who need to regulate intestinal function
Release of "Bioris C," a New Bowel-regulating Quasi-drug

Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) will release a new bowel regulator, Bioris C, on December 24. It contains three types of lactic acid bacteria, and vitamin C.

An unbalanced diet, lack of exercise, stress, and disregard for the urge to defecate when a person is busy are all characteristics of modern lifestyles. They are a burden on the stomach and intestines, and are one of the causes of imbalances in intestinal bacteria.

Bioris C is a bowel regulator containing three types of lactic acid bacteria (Lactobacillus acidophilus, Streptococcus faecalis and Bifidobacterium bifidum), and vitamin C. The acid that is produced by these bacteria reduces intestinal pH to prevent proliferation of harmful bacteria and regulate intestinal function. Excellent effects will be achieved by taking one tablet three times a day. The chewable, lemon-flavored tablet can be taken anywhere and without water.

Product features
- Contains three types of lactic acid bacteria, and vitamin C
- Water is not required with this chewable, lemon-flavored tablet
- One tablet three times a day

Product specification

Product name Bioris C
Suggested retail price 18 tablets: ¥787 (¥750 product + ¥37 tax)
One tablet contains: 
Lactomin 10 mg
(Lactobacillus acidophilus)
Lactomin 10 mg
(Streptococcus faecalis)
Bifidobacterium bifidum 10 mg
Ascorbic acid (vitamin C) 166.7 mg
(3 tablets contain 500 mg)
Indications Regulates intestinal function (regulates bowel movement), and alleviates constipation, soft stool and abdominal bloating.
Dosage Take the following dose after meals by chewing or sucking on tablets.
Age Adults
 (15 years or older)
Less than 15 years
Single dose 1 tablet Do not use.
Frequency Three times a day
Date of sale December 24, 2004
Expected sales ¥100 million(one year from date of sale)